Brief: Dawnrays Pharmaceutical (Holdings) Posts HY Profit Attributable Of RMB 129.7 Mln
25/08/2020 12:28
Aug 25 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
2348.HK :
* HY PROFIT ATTRIBUTABLE RMB 129.7 MILLION VERSUS RMB 150.4
MILLION
* HY REVENUE RMB 489 MILLION VERSUS RMB 490.8 MILLION
* DECLARED AN INTERIM DIVIDEND HK$0.015 PER SHARE
Source text https://bit.ly/2Efiafv
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO